STOCK TITAN

Elanco (ELAN) officer uses 3,371 common shares to cover tax withholding

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Elanco Animal Health Inc officer Jose Manuel Correia de Simas reported a tax-related share disposition. On March 3, 2026, he transferred 3,371 shares of common stock at $24.88 per share to cover tax withholding, and held 101,017 shares directly afterward.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Correia de Simas Jose Manuel

(Last) (First) (Middle)
C/O ELANCO ANIMAL HEALTH INCORPORATED
450 ELANCO CIRCLE

(Street)
INDIANAPOLIS IN 46221

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
SEE REMARKS
3. Date of Earliest Transaction (Month/Day/Year)
03/03/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/03/2026 F 3,371 D $24.88 101,017 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
Executive Vice President, US Farm Animal Business
/s/ Amy C. Seidel, as Attorney-in-Fact for Jose Manuel Correia de Simas 03/05/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Jose Manuel Correia de Simas report at Elanco (ELAN)?

Jose Manuel Correia de Simas reported a tax-withholding share disposition at Elanco. He transferred 3,371 shares of common stock to satisfy tax obligations, using stock instead of cash, and remained a direct shareholder after the transaction.

How many Elanco (ELAN) shares were used for tax withholding?

The officer used 3,371 Elanco common shares for tax withholding. These shares were disposed of as part of a tax-payment mechanism, where stock is surrendered to cover liabilities instead of paying the taxes in cash.

At what price were the Elanco (ELAN) shares valued in this Form 4 filing?

The Form 4 shows the 3,371 common shares valued at $24.88 per share. This price is used to calculate the value of shares applied toward the officer’s tax obligation through the stock-based withholding arrangement.

How many Elanco (ELAN) shares does the reporting officer hold after the transaction?

After the tax-withholding disposition, the reporting officer directly held 101,017 Elanco common shares. This figure reflects his remaining direct ownership following the transfer of 3,371 shares to cover the associated tax liability.

Was the Elanco (ELAN) insider transaction an open-market sale?

No, the transaction was classified as a tax-withholding disposition, not an open-market sale. Shares were delivered to satisfy a tax liability, a common administrative mechanism rather than a discretionary trade in the open market.

What kind of security was involved in Jose Manuel Correia de Simas’s Elanco (ELAN) transaction?

The transaction involved Elanco common stock. The officer disposed of 3,371 common shares through a tax-withholding arrangement, with the activity reported as a non-derivative transaction in the Form 4 filing submitted to regulators.
Elanco Animal Health

NYSE:ELAN

ELAN Rankings

ELAN Latest News

ELAN Latest SEC Filings

ELAN Stock Data

12.15B
490.37M
Drug Manufacturers - Specialty & Generic
Pharmaceutical Preparations
Link
United States
INDIANAPOLIS